Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. R3g3hb38o4
2. Gallium, Tris(8-quinolinolato)-
3. Tris(8-hydroxyquinolinato)gallium
4. Nkp-2235
5. Ap-002
6. It-235
7. Lx-001
8. Gallium;quinolin-8-olate
9. Unii-r3g3hb38o4
10. Kp46
11. Nsc 158197
12. Nsc-158197
13. Gallium, Tris(8-quinolinolato-kappan1,kappao8)-
14. Gallium, Tris(8-quinolinolato-.kappa.n1,.kappa.o8)-
| Molecular Weight | 502.2 g/mol |
|---|---|
| Molecular Formula | C27H18GaN3O3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 0 |
| Exact Mass | 501.06039 g/mol |
| Monoisotopic Mass | 501.06039 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 138 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
ABOUT THIS PAGE
34
PharmaCompass offers a list of AP-002 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AP-002 manufacturer or AP-002 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AP-002 manufacturer or AP-002 supplier.
PharmaCompass also assists you with knowing the AP-002 API Price utilized in the formulation of products. AP-002 API Price is not always fixed or binding as the AP-002 Price is obtained through a variety of data sources. The AP-002 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AP-002 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AP-002, including repackagers and relabelers. The FDA regulates AP-002 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AP-002 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AP-002 supplier is an individual or a company that provides AP-002 active pharmaceutical ingredient (API) or AP-002 finished formulations upon request. The AP-002 suppliers may include AP-002 API manufacturers, exporters, distributors and traders.
AP-002 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AP-002 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AP-002 GMP manufacturer or AP-002 GMP API supplier for your needs.
A AP-002 CoA (Certificate of Analysis) is a formal document that attests to AP-002's compliance with AP-002 specifications and serves as a tool for batch-level quality control.
AP-002 CoA mostly includes findings from lab analyses of a specific batch. For each AP-002 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AP-002 may be tested according to a variety of international standards, such as European Pharmacopoeia (AP-002 EP), AP-002 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AP-002 USP).
